Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Gareth R Evans

Showing results (51-60 of 102) with videos related to

Pageof 11
Sort By:
European Journal of Cancer (Oxford, England : 1990)|April 29, 2006
BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relativesFiona Lalloo, Jennifer Varley, Anthony Moran, et al.
JAMA Oncology|January 19, 2018
Use of Single-Nucleotide Polymorphisms and Mammographic Density Plus Classic Risk Factors for Breast Cancer Risk PredictionElke M van Veen, Adam R Brentnall, Helen Byers, et al.
Hereditary Cancer in Clinical Practice|January 27, 2018
Genetic variants of prospectively demonstrated phenocopies in <i>BRCA1/2</i> kindredsMev Dominguez-Valentin, D Gareth R Evans, Sigve Nakken, et al.
Oncogene|March 16, 2002
Contribution of cyclin d1 (CCND1) and E-cadherin (CDH1) polymorphisms to familial and sporadic colorectal cancerTimothy R Porter, Frances M Richards, Richard S Houlston, et al.
Cancers|January 11, 2024
Real-World Concordance between Germline and Tumour <i>BRCA1/2</i> Status in Epithelial Ovarian CancerRobert D Morgan, George J Burghel, Helene Schlecht, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 10, 2019
Breast cancer in neurofibromatosis 1: survival and risk of contralateral breast cancer in a five country cohort studyD Gareth R Evans, Roope A Kallionpää, Maurizio Clementi, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 9, 2019
Correction: Breast cancer in neurofibromatosis 1: survival and risk of contralateral breast cancer in a five country cohort studyD Gareth R Evans, Roope A Kallionpää, Maurizio Clementi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 2, 2009
Eligibility for magnetic resonance imaging screening in the United Kingdom: effect of strict selection criteria and anonymous DNA testing on breast cancer incidence in the MARIBS StudyD Gareth R Evans, Fiona Lennard, Linda J Pointon, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 9, 2005
Evidence for an association between compound heterozygosity for germ line mutations in the hemochromatosis (HFE) gene and increased risk of colorectal cancerJames P Robinson, Victoria L Johnson, Pauline A Rogers, et al.
Clinical Endocrinology|February 21, 2004
Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibilityDewi Astuti, Niki Hart-Holden, Farida Latif, et al.
Pageof 11

Showing results (51-60 of 102) with videos related to

Sort By:
Pageof 11
European Journal of Cancer (Oxford, England : 1990)|April 29, 2006
BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relativesFiona Lalloo, Jennifer Varley, Anthony Moran, et al.
JAMA Oncology|January 19, 2018
Use of Single-Nucleotide Polymorphisms and Mammographic Density Plus Classic Risk Factors for Breast Cancer Risk PredictionElke M van Veen, Adam R Brentnall, Helen Byers, et al.
Hereditary Cancer in Clinical Practice|January 27, 2018
Genetic variants of prospectively demonstrated phenocopies in <i>BRCA1/2</i> kindredsMev Dominguez-Valentin, D Gareth R Evans, Sigve Nakken, et al.
Oncogene|March 16, 2002
Contribution of cyclin d1 (CCND1) and E-cadherin (CDH1) polymorphisms to familial and sporadic colorectal cancerTimothy R Porter, Frances M Richards, Richard S Houlston, et al.
Cancers|January 11, 2024
Real-World Concordance between Germline and Tumour <i>BRCA1/2</i> Status in Epithelial Ovarian CancerRobert D Morgan, George J Burghel, Helene Schlecht, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 10, 2019
Breast cancer in neurofibromatosis 1: survival and risk of contralateral breast cancer in a five country cohort studyD Gareth R Evans, Roope A Kallionpää, Maurizio Clementi, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 9, 2019
Correction: Breast cancer in neurofibromatosis 1: survival and risk of contralateral breast cancer in a five country cohort studyD Gareth R Evans, Roope A Kallionpää, Maurizio Clementi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 2, 2009
Eligibility for magnetic resonance imaging screening in the United Kingdom: effect of strict selection criteria and anonymous DNA testing on breast cancer incidence in the MARIBS StudyD Gareth R Evans, Fiona Lennard, Linda J Pointon, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 9, 2005
Evidence for an association between compound heterozygosity for germ line mutations in the hemochromatosis (HFE) gene and increased risk of colorectal cancerJames P Robinson, Victoria L Johnson, Pauline A Rogers, et al.
Clinical Endocrinology|February 21, 2004
Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibilityDewi Astuti, Niki Hart-Holden, Farida Latif, et al.
Pageof 11